eptinezumabgalcanezumaberenumabmigraineanti-CGRP therapies
…frequent for erenumab (31%), followed by galcanezumab (27%) and eptinezumab (15%).Conclusion and Relevance Treatment effectiveness was obse…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 138 of 876voriconazoletertiary level hospitalinflammationinflammatory processes
…here may be situations of intoxication by certain drugs such as voriconazole.Aim and Objectives To analyse the influence between C-reactive …
paclitaxelEpirubicinepirubicin-cyclophosphamidePbreast cancertertiary hospital
…eekly P due to intolerance and eleven patients did not complete paclitaxel: four due to severe infusional reaction, two due to myelotoxici…
BaricitinibtofacitinibupadacitinibAbrocitinibADatopic dermatitiscardiac disorders
… JAK inhibitors-related AERs extracted from the FAERS database. Baricitinib was associated with an elevated risk of cardiac disorders (ROR=…
metamizoleMetamizole-associatedMetamizole-induceddipyroneagranulocytosis
…heva D, et al. Genetic factors and risk of agranulocytosis from metamizole. Pharmacogenetics. 1996;6:67–72.4. Shah RR. Metamizole-induced …
proton pump inhibitorsvitaminsPIMsComprehensive Pharmacotherapy Assessment ProgramCPAPtertiary hospitalCPAPComplex chronic patients
…Pharmacotherapeutic group most frequently associated with PIMs: proton pump inhibitors 64 (11.7%) and vitamins 49 (9.0%).Conclusion and Relevance Near…
glimepiridegliclazideglyburidemetforminbiguanidediabetesnon-communicable diseases
…ide (metformin) and three sulfonylureas (glyburide, gliclazide, glimepiride). Drugs were collected from licensed pharmacies and street mark…
afliberceptAFL-8faricimabneovascular age-related macular degenerationdiabetic macular oedemaComisión Interministerial de Precios de MedicamentosnAMDDME
…f aflibercept 8 mg (AFL-8) compared to faricimab 6 mg (FAR) and aflibercept 2 mg (AFL-2).Material and Methods Clinical trial data of phase …
NTZnatalizumabADAbmultiple sclerosisOslo University HospitalpwMS
…University Hospital were switched from originator to biosimilar NTZ. We prospectively evaluated disease activity, safety, serum dru…
ursodeoxycholic acid (UDCA)obeticholic acid (OCA)UDCAOCAPrimary biliary cholangitis (PBC)PBCLondon – Riverside Research Ethics Committee
…atment approach is a step-up model, wherein first-line therapy, ursodeoxycholic acid (UDCA), is given for a minimum of 12 months before the addition of sec…
rituximabaspirinhydroxychloroquinealprostadilstatinsantiphospholipid syndromeperipheral arterial diseasedry gangreneocclusive artery diseasethromboangiitis obliterans+2 more
…t to standard anticoagulant therapy and requires treatment with rituximab with good effect.…
CalprotectinSystemic lupus erythematosusSLEBühlmann Laboratories AG
…itzerland) according to the manufacturer’s instructions.Results Calprotectin levels were significantly higher in SLE patients compared to th…